50 Million euro investment for LUMC spin-off RougeTx advances therapies for inherited bleeding disorders.
On January 8, Professor Kim Jensen has stepped into the position of Node Director of the Copenhagen Node of the Novo Nordisk Foundation Center for Stem Cell Medicine – reNEW in place of Professor Melissa Little.
Melissa Little will continue her role as CEO of reNEW and as Principal Investigator at her research labs in Copenhagen at Faculty of Health and Medical Sciences, UCPH and in Melbourne at Murdoch Children’s Research Institute (MCRI).
Melissa Little: ‘I am delighted to hand the reins to Kim who has already been playing a critical role on the ground in Copenhagen. I have every confidence in his ability to steer you all through the local challenges with his positive approach and strategic experience.’
Kim: ‘I am thrilled to embrace the role of Node Director in Copenhagen, eager to build upon the incredible momentum we’ve cultivated through reNEW under Melissa’s exceptional local and global leadership. I eagerly anticipate the challenges and the exciting journey that lies ahead.’
